Andrew D Ho, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 22
- 4 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
22 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ho’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
22 of 22 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A109930 · Current
Licensed to practise in California · since 2009 · expires 2027-09-30 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$12,457
Medicare paid this office $12,457 for 84 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,386 | $130 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,320 | $102 |
| Return visit (30+ min) | 16 | $1,313 | $73 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 31 | $142 | $4 |
Procedures Medicare counted
| Colonoscopy | 61 | More than 68% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 19 | More than 50% of doctors who do this |
Who their Medicare patients are
84 Original Medicare patients in 2024. Average age 71 · Women 45% · Also on Medicaid 81% · Health risk score 2.10. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 67% · Diabetes 50% · Chronic kidney disease 25% · Heart failure 24% · Depression 24% · Cancer 20% · Coronary heart disease 18% · Atrial fibrillation 18% · COPD 15% · Dementia 14%.
The office billed $152,901, Medicare allowed $18,601 and paid $12,457; for 152 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 84 | 152 | 71 | 2.10 | $152,901 | $12,457 |
| 2023 | 128 | 245 | 71 | 2.16 | $256,619 | $22,841 |
| 2022 | 93 | 196 | 70 | 2.68 | $180,910 | $18,367 |
| 2021 | 158 | 329 | 72 | 2.26 | $283,245 | $25,668 |
| 2020 | 177 | 334 | 70 | 2.11 | $268,018 | $26,628 |
| 2019 | 189 | 374 | 70 | 1.96 | $321,947 | $30,445 |
| 2016 | 51 | 68 | 68 | 1.77 | $51,928 | $6,024 |
| 2015 | 70 | 120 | 68 | 1.81 | $115,311 | $12,637 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,678 | $167 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 18 | $4,203 | $221 |
| Long return visit (40+ min) | 23 | $3,469 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,598 | $114 |
| Return visit (30+ min) | 16 | $1,536 | $85 |
| Biopsy of large bowel using a flexible endoscope | 15 | $1,420 | $89 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,024 | $93 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 49 | $218 | $4 |
2022: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,785 | $210 |
| Long return visit (40+ min) | 23 | $3,575 | $149 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $1,974 | $164 |
| Biopsy of large bowel using a flexible endoscope | 11 | $1,434 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,227 | $112 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,087 | $99 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 44 | $211 | $5 |
2021: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 20 | $4,110 | $206 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $3,476 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,625 | $114 |
| Diagnostic exam of large bowel using a flexible endoscope | 17 | $2,608 | $153 |
| Return visit (30+ min) | 22 | $2,278 | $104 |
| Telephone medical discussion with physician, 5-10 minutes | 49 | $1,769 | $32 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $1,760 | $88 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,150 | $105 |
| Biopsy of large bowel using a flexible endoscope | 21 | $1,101 | $52 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 73 | $342 | $5 |
2020: 11 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 47 | $6,677 | $142 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $3,090 | $221 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,312 | $105 |
| Telephone medical discussion with physician, 11-20 minutes | 44 | $2,247 | $47 |
| Biopsy of large bowel using a flexible endoscope | 18 | $2,035 | $113 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 21 | $2,015 | $96 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,365 | $114 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $779 | $71 |
| Return visit (30+ min) | 15 | $751 | $50 |
| Telephone medical discussion with physician, 5-10 minutes | 21 | $524 | $23 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 55 | $261 | $5 |
2019: 10 services
| Biopsy of large bowel using a flexible endoscope | 40 | $4,363 | $106 |
| New patient visit (45+ min) | 43 | $4,281 | $100 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | $4,206 | $200 |
| Return visit (30+ min) | 54 | $4,107 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $3,106 | $119 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $2,656 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,799 | $90 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,250 | $114 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,175 | $90 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 68 | $333 | $5 |
2016: 2 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,548 | $119 |
| Return visit (30+ min) | 21 | $880 | $40 |
2015: 3 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,065 | $115 |
| Return visit (30+ min) | 30 | $1,932 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,386 | $87 |
Medicaid work
$29,226 in 2024
Medicaid paid $29,226 for 2,692 billed services this clinician did in 2024, up to 63 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Service | 312 | $7,668 |
| Upper gastrointestinal endoscopy with biopsy | 161 | $3,767 |
| COLONOSCOPY AND BIOPSY | 143 | $3,734 |
| COLONOSCOPY W/LESION REMOVAL | 71 | $3,075 |
| Diagnostic upper gastrointestinal endoscopy | 27 | $2,125 |
| TISSUE EXAM BY PATHOLOGIST | 383 | $1,811 |
| Return visit (30+ min) | 125 | $1,635 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 72 | $1,531 |
| DIAGNOSTIC COLONOSCOPY | 26 | $1,176 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 34 | $983 |
| Long return visit (40+ min) | 35 | $628 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 16 | $412 |
| 2024 | 2,692 | 22 | 63 | $29,226 |
| 2023 | 1,686 | 17 | 36 | $17,884 |
| 2022 | 453 | 9 | 40 | $4,605 |
| 2021 | 630 | 13 | 33 | $10,791 |
| 2020 | 374 | 10 | 28 | $10,720 |
| 2019 | 709 | 10 | 46 | $10,142 |
| 2018 | 1,082 | 12 | 34 | $16,267 |
See the largest Medicaid services in earlier years
2023
| COLONOSCOPY AND BIOPSY | 144 | $5,262 |
| Upper gastrointestinal endoscopy with biopsy | 101 | $2,332 |
| COLONOSCOPY W/LESION REMOVAL | 56 | $2,286 |
| TISSUE EXAM BY PATHOLOGIST | 351 | $2,051 |
| Long return visit (40+ min) | 118 | $1,610 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 51 | $1,160 |
| Service | 194 | $1,093 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 34 | $921 |
| Return visit (30+ min) | 85 | $643 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 277 | $217 |
| 5% dextrose/normal saline (500 ml = 1 unit) | 170 | $143 |
| New patient visit (30+ min) | 12 | $95 |
2022
| COLONOSCOPY AND BIOPSY | 27 | $1,252 |
| Return visit (30+ min) | 55 | $830 |
| TISSUE EXAM BY PATHOLOGIST | 34 | $815 |
| COLONOSCOPY W/LESION REMOVAL | 12 | $668 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 13 | $549 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 254 | $333 |
| Short return visit | 14 | $91 |
| Long return visit (40+ min) | 14 | $56 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 30 | $12 |
2021
| Upper gastrointestinal endoscopy with biopsy | 30 | $2,413 |
| Return visit (30+ min) | 174 | $2,348 |
| COLONOSCOPY AND BIOPSY | 27 | $1,729 |
| TISSUE EXAM BY PATHOLOGIST | 32 | $1,380 |
| DIAGNOSTIC COLONOSCOPY | 12 | $1,118 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 213 | $576 |
| New patient visit (45+ min) | 18 | $327 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 12 | $217 |
| New patient visit (30+ min) | 12 | $185 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 13 | $168 |
| Short return visit (20+ min) | 19 | $156 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 12 | $141 |
2020
| COLONOSCOPY AND BIOPSY | 41 | $4,252 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 141 | $1,813 |
| Upper gastrointestinal endoscopy with biopsy | 26 | $1,760 |
| COLONOSCOPY W/LESION REMOVAL | 12 | $527 |
| TISSUE EXAM BY PATHOLOGIST | 13 | $524 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 19 | $473 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 20 | $437 |
| Return visit (30+ min) | 34 | $424 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 14 | $328 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 54 | $183 |
2019
| Return visit (30+ min) | 304 | $2,326 |
| COLONOSCOPY AND BIOPSY | 52 | $1,414 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 126 | $1,261 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 32 | $1,238 |
| Diagnostic upper gastrointestinal endoscopy | 12 | $934 |
| COLONOSCOPY W/LESION REMOVAL | 14 | $829 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 50 | $776 |
| TISSUE EXAM BY PATHOLOGIST | 15 | $702 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 51 | $417 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 53 | $245 |
2018
| Service | 175 | $4,916 |
| TISSUE EXAM BY PATHOLOGIST | 171 | $3,052 |
| COLONOSCOPY AND BIOPSY | 85 | $2,881 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 107 | $2,010 |
| Return visit (30+ min) | 167 | $1,598 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 40 | $961 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 144 | $504 |
| New patient visit (45+ min) | 22 | $119 |
| 5% dextrose/normal saline (500 ml = 1 unit) | 67 | $73 |
| Upper gastrointestinal endoscopy with biopsy | 12 | $56 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 78 | $50 |
| Special stain including interpretation and report; Group I for microorganisms (eg, acid fast, methenamine silver) | 14 | $47 |
Drugs they prescribed that Part D paid
$524,158
Pharmacies billed $524,158 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 297) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
191 generic and 106 brand-name prescriptions · $524,158 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Skyrizi on-Body | 12 | $218,237 | $18,186 |
| Vemlidy | 21 | $28,385 | $1,352 |
| Linzess | 32 | $17,232 | $539 |
| Balsalazide Disodium | 25 | $2,965 | $119 |
| Loperamide | 14 | $313 | $22 |
See all 9 drugs
| Skyrizi on-Body | 12 | $218,237 | $18,186 |
| Vemlidy | 21 | $28,385 | $1,352 |
| Linzess | 32 | $17,232 | $539 |
| Balsalazide Disodium | 25 | $2,965 | $119 |
| Loperamide | 14 | $313 | $22 |
| Peg-3350 and Electrolytes | 12 | $230 | $19 |
| Pantoprazole | 20 | $195 | $10 |
| Omeprazole | 22 | $140 | $6 |
| Ondansetron | 17 | $80 | $5 |
Year by year
| 2024 | 297 | 60 | 0% (0) | 36% | $524,158 |
| 2023 | 303 | 75 | 0% (0) | 37% | $408,705 |
| 2022 | 295 | 65 | 0% (0) | 35% | $457,049 |
| 2021 | 330 | 104 | 0% (0) | 37% | $519,462 |
| 2020 | 312 | 99 | 0% (0) | None | $260,795 |
| 2019 | 222 | 87 | 0% (0) | 51% | $446,863 |
| 2018 | 246 | 95 | None | 37% | $416,593 |
| 2017 | 272 | 95 | None | 33% | $252,778 |
| 2016 | 181 | 60 | None | None | $476,727 |
| 2015 | 77 | 32 | None | 35% | $116,597 |
| 2014 | 42 | 16 | None | None | $8,725 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Linzess | 34 | $19,325 | $568 |
| Creon | 11 | $18,316 | $1,665 |
| Mesalamine | 12 | $13,004 | $1,084 |
| Balsalazide Disodium | 20 | $3,112 | $156 |
| Lubiprostone | 16 | $3,099 | $194 |
| Loperamide | 18 | $1,584 | $88 |
| Entecavir | 11 | $1,058 | $96 |
| Peg-3350 and Electrolytes | 21 | $514 | $24 |
| Omeprazole | 28 | $367 | $13 |
| Gavilyte-G | 17 | $321 | $19 |
| Dicyclomine | 11 | $177 | $16 |
2022: 11 drugs
| Stelara | 16 | $394,783 | $24,674 |
| Creon | 13 | $24,652 | $1,896 |
| Linzess | 26 | $13,512 | $520 |
| Lubiprostone | 17 | $5,305 | $312 |
| Balsalazide Disodium | 24 | $3,814 | $159 |
| Loperamide | 18 | $1,495 | $83 |
| Entecavir | 16 | $1,451 | $91 |
| Pantoprazole | 11 | $344 | $31 |
| Peg-3350 and Electrolytes | 17 | $262 | $15 |
| Omeprazole | 30 | $255 | $9 |
| Gavilyte-G | 13 | $205 | $16 |
2021: 13 drugs
| Stelara | 17 | $399,246 | $23,485 |
| Linzess | 32 | $15,324 | $479 |
| Mesalamine | 13 | $5,460 | $420 |
| Amitiza | 11 | $4,314 | $392 |
| Balsalazide Disodium | 24 | $2,033 | $85 |
| Entecavir | 17 | $2,015 | $119 |
| Loperamide | 16 | $555 | $35 |
| Omeprazole | 31 | $282 | $9 |
| Pantoprazole | 15 | $231 | $15 |
| Peg-3350 and Electrolytes | 17 | $213 | $13 |
| Gavilyte-G | 12 | $189 | $16 |
| Golytely | 11 | $128 | $12 |
| Dicyclomine | 12 | $97 | $8 |
2020: 9 drugs
| Mesalamine | 15 | $10,702 | $713 |
| Linzess | 20 | $10,649 | $532 |
| Carafate | 23 | $4,792 | $208 |
| Balsalazide Disodium | 20 | $2,549 | $127 |
| Entecavir | 14 | $1,827 | $131 |
| Peg-3350 and Electrolytes | 33 | $401 | $12 |
| Pantoprazole | 33 | $265 | $8 |
| Omeprazole | 32 | $216 | $7 |
| Dicyclomine | 13 | $89 | $7 |
2019: 7 drugs
| Stelara | 15 | $324,797 | $21,653 |
| Creon | 12 | $8,832 | $736 |
| Entecavir | 12 | $7,837 | $653 |
| Linzess | 14 | $5,869 | $419 |
| Balsalazide Disodium | 11 | $1,150 | $105 |
| Peg-3350 and Electrolytes | 41 | $551 | $13 |
| Omeprazole | 15 | $138 | $9 |
2018: 8 drugs
| Stelara | 16 | $339,761 | $21,235 |
| Entecavir | 24 | $22,107 | $921 |
| Creon | 14 | $8,560 | $611 |
| Linzess | 14 | $5,275 | $377 |
| Polyethylene Glycol 3350 | 22 | $572 | $26 |
| Peg-3350 and Electrolytes | 32 | $415 | $13 |
| Gavilyte-G | 23 | $361 | $16 |
| Pantoprazole | 11 | $187 | $17 |
2017: 6 drugs
| Viread | 11 | $4,686 | $426 |
| Polyethylene Glycol 3350 | 30 | $538 | $18 |
| Peg-3350 and Electrolytes | 30 | $390 | $13 |
| Gavilyte-G | 12 | $177 | $15 |
| Prednisone | 13 | $176 | $14 |
| Omeprazole | 16 | $128 | $8 |
2016: 3 drugs
| Polyethylene Glycol 3350 | 24 | $641 | $27 |
| Peg-3350 and Electrolytes | 17 | $225 | $13 |
| Omeprazole | 33 | $206 | $6 |
Money from drug and device companies
$144 in 2025
| 2025 | 4 | 4 | None | $144 |
| 2024 | 1 | 2 | None | $84 |
| 2023 | 1 | 3 | $2,813 | $2,831 |
| 2022 | 1 | 7 | $12,969 | $13,861 |
| 2021 | 1 | 5 | $6,000 | $6,274 |
| 2019 | 1 | 16 | $17,400 | $19,797 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $67 | 1 payment
|
| Novo Nordisk | None | $34 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | None | $28 | 1 payment
|
| Chiesi USA | Kengreal | $14 | 1 payment
|
See all 4 published payments
| Chiesi USA | Meals · 2025-10-16 | Kengreal | $14 |
| Heartflow | Meals · 2025-05-16 | Ffrct | $67 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-05 | None | $28 |
| Novo Nordisk | Meals · 2025-05-04 | None | $34 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $84
| Heartflow | Ffrct | $84 | 2 payments
|
2023: $2,831
| Abbvie | Rinvoq | $2,831 | 3 payments
|
2022: $13,861
| Abbvie | Skyrizi | $13,861 | 7 payments
|
2021: $6,274
| AbbVie | Humira | $6,274 | 5 payments
|
2019: $19,797
| AbbVie | Humira | $19,797 | 16 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1033361225
- Licence
- CA A109930California A109930: Current · expires 2027-09-30
- Trained
- University of California, San Diego School of Medicine, 2008
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 8700 Beverly Blvd, West Hollywood, CA, 90048
- NPI first listed
- 2008-10-21
- NPI last updated
- 2011-10-16
This is when the NPI record was last certified, not a medical board exam.